Litcius/Paper detail

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

Laura Mezquita, Isabel R. Preeshagul, Édouard Auclin, D. Saravia, Lizza Hendriks, Hira Rizvi, Wungki Park, Ernest Nadal, Patricia Martín-Romano, J.C. Ruffinelli, Santiago Ponce, Clarisse Audigier-Valette, Simona Carnio, Félix Blanc‐Durand, Paolo Bironzo, Fabrizio Tabbò, Maria Lucia Reale, Silvia Novello, Matthew D. Hellmann, Peter Sawan, Jeffrey Girshman, Andrew J. Plodkowski, Gérard Zalcman, Margarita Majem, Mélinda Charrier, Marie Naigeon, Caroline Rossoni, Annapaola Mariniello, Luis Paz‐Ares, Anne‐Marie C. Dingemans, David Planchard, Nathalie Cozic, Lydie Cassard, Gilberto Lopes, Nathalie Chaput, Kathryn C. Arbour, Benjamin Besse

2021European Journal of Cancer60 citationsDOIOpen Access PDF

Topics & Concepts

Internal medicineMedicineCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisImmune cells in cancer
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics | Litcius